HealthAssure
HealthAssureGood Life
LOINCActiveBoth

LOINC Code 82675-0: HPV 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA NAA+probe Ql (Cvx)

82675-0 is a LOINC code used to identify HPV 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA NAA+probe Ql (Cvx) in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA. It is commonly used with the system or sample type Cvx.

Reviewed by HealthAssure Clinical TeamUpdated 21 May 2026

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA. It is commonly used with the system or sample type Cvx.

When is it used?

  • Used in lab systems, EHRs, and clinical data exchange.
  • May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
  • Status: ACTIVE
  • Order vs observation: Both
  • Method: Probe.amp.tar

What it does not mean

  • The code identifies the observation or test, not the actual result.

Key facts

Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by NAA with probe detection
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA
This test detects any one of, or combination of, the following 14 high risk human papillomavirus (HPV) genotypes16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68. This test does not differentiate between HPV genotypes.
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cervix; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; Genital warts; Gyn; Gynecology; HPV; HPV I/H Risk 4; HPV16; HPV16 and 18; HPV16+18; HPV16+18+H Risk 12; HPV16+18+HRisk12DNA; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; Papilloma virus high risk; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

HPV 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA NAA+probe Ql (Cvx)Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by NAA with probe detectionHPV I/H Risk 4 DNA Cvx Ql NAA+probeHuman papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNAMICROHPV 16+18+31+33+35+39+45+51+52+56+58+59+66+68, CervixPrThr

Frequently asked questions

Code details

Code82675-0
SystemLOINC
Display nameHPV 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA NAA+probe Ql (Cvx)
DescriptionHuman papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA
Short nameHPV I/H Risk 4 DNA Cvx Ql NAA+probe
ComponentHuman papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA
PropertyPrThr
TimingPt
System (specimen)Cvx
ScaleOrd
MethodProbe.amp.tar
ClassMICRO
StatusACTIVE
Order/ObservationBoth

Flags

BillableNo
Valid clinical useNo

Source

SourceLOINC
Version2.82
Releasemain
First released2.58
Last changed2.73

Consumer names

HPV 16+18+31+33+35+39+45+51+52+56+58+59+66+68, Cervix

Part names

Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNAPrThrPtCvxOrdProbe.amp.tarHuman papilloma virus16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNAPresence or ThresholdPoint in time (spot)CervixNucleic acid amplification with probe detection

About this content

This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.